ALNYLAM PHARMACEUTICALS, INC.;ALNYLAM PHARMACEUTICALS; INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
发明人:
BETTENCOURT, BRIAN,FITZGERALD, KEVIN,QUERBES, WILLIAM,YASUDA, MAKIKO,DESNICK, ROBERT J.
申请号：
CA2868290
公开号：
CA2868290A1
申请日:
2013.04.10
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The invention relates to double- stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g.,inhibit) expression of ALAS1.
